A Novel Pyroptosis-related Prognostic Model for Hepatocellular Carcinoma
Authors:
Open Access
- 15 November 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 9
Abstract
Hepatocellular carcinoma (HCC) is the second most lethal malignant tumor because of its significant heterogeneity and complicated molecular pathogenesis. Novel prognostic biomarkers are urgently needed because no effective and reliable prognostic biomarkers currently exist for HCC patients. Increasing evidence has revealed that pyroptosis plays a role in the occurrence and progression of malignant tumors. However, the relationship between pyroptosis-related genes (PRGs) and HCC patient prognosis remains unclear. In this study, 57 PRGs were obtained from previous studies and GeneCards. The gene expression profiles and clinical data of HCC patients were acquired from public data portals. Least absolute shrinkage and selection operator (LASSO) Cox regression analysis was performed to establish a risk model using TCGA data. Additionally, the risk model was further validated in an independent ICGC dataset. Our results showed that 39 PRGs were significantly differentially expressed between tumor and normal liver tissues in the TCGA cohort. Functional analysis confirmed that these PRGs were enriched in pyroptosis-related pathways. According to univariate Cox regression analysis, 14 differentially expressed PRGs were correlated with the prognosis of HCC patients in the TCGA cohort. A risk model integrating two PRGs was constructed to classify the patients into different risk groups. Poor overall survival was observed in the high-risk group of both TCGA (p < 0.001) and ICGC (p < 0.001) patients. Receiver operating characteristic curves demonstrated the accuracy of the model. Furthermore, the risk score was confirmed as an independent prognostic indicator via multivariate Cox regression analysis (TCGA cohort: HR = 3.346, p < 0.001; ICGC cohort: HR = 3.699, p < 0.001). Moreover, the single-sample gene set enrichment analysis revealed different immune statuses between high- and low-risk groups. In conclusion, our new pyroptosis-related risk model has potential application in predicting the prognosis of HCC patients.Keywords
This publication has 37 references indexed in Scilit:
- Intratumor Molecular and Phenotypic Diversity in Hepatocellular CarcinomaClinical Cancer Research, 2015
- Induction of pyroptosis in colon cancer cells by LXRβMolecular & Cellular Oncology, 2014
- Trans-ancestry mutational landscape of hepatocellular carcinoma genomesNature Genetics, 2014
- Inflammasomes as molecular mediators of inflammation and cancer: Potential role in melanomaCancer Letters, 2012
- The DFNA5 gene, responsible for hearing loss and involved in cancer, encodes a novel apoptosis-inducing proteinEuropean Journal of Human Genetics, 2011
- Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4Proceedings of the National Academy of Sciences, 2010
- The substrates of Plk1, beyond the functions in mitosisProtein & Cell, 2010
- Increased Regulatory T Cells Correlate With CD8 T-Cell Impairment and Poor Survival in Hepatocellular Carcinoma PatientsGastroenterology, 2007
- Nod-like proteins in immunity, inflammation and diseaseNature Immunology, 2006
- Polo-like kinases (Plks) and cancerOncogene, 2005